Calls
At ECRIN, we can provide support to investigators in preparing proposals for multinational clinical study funding, provided the project meets ECRIN’s eligibility criteria.
For more information on how ECRIN can support you in the preparation of these calls, see Clinical Trials Preparation and contact your local European Correspondent.
For more information and guidance on Horizon Europe funding schemes and opportunities, you are encouraged to contact your National Contact Point (NCP). Additional details on funding opportunities and events under Cluster 1 – Health are also available on the HNN3 network website, which brings together NCPs in the health area.
The calls listed below may be relevant for your applications for clinical trials / clinical research in various fields. In the News section of our website, you can also find additional information on calls on diverse topics other than clinical trials.
Discover the European funding programs for multinational clinical trials.
Call Launch :
Deadline :
Deadline 2 :
Description :
Innovative healthcare interventions for non-communicable diseases - Cluster 1 - Health (Two stage - 2027) (HORIZON-HLTH-2027-02-two-stage).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Researchers, developers and clinical practitioners have access to state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to develop innovative healthcare interventions aimed at reducing burden of the following specific Non-Communicable Diseases (NCDs): cardiovascular diseases, diabetes, chronic respiratory diseases or chronic kidney diseases.
- Scientific and clinical communities can use innovative healthcare interventions to generate meaningful advances in clinical practice and care for patients with NCDs following validation in late-stage clinical trials.
- Scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR[1] principles, thereby encouraging further use of the data.
- Policymakers, scientific and clinical communities, developers, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches.
- Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for, with the aim of tangibly benefitting from the interventions.
Call Launch :
Deadline :
Description :
Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) - Supporting the implementation of the Cancer Mission (HORIZON-MISS-2026-02-CANCER-05).
Expected Outcome:
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:
- Through the European Cancer Patient Digital Centre (ECPDC), adolescent and young cancer patients and survivors as well as their caregivers have access to innovative tools and approaches to strengthen their mental health.
- Healthcare professionals have access to innovative tools to monitor and support the mental health of cancer patients and survivors as well as their caregivers.
- Researchers and healthcare professionals have access and use reliable patient reported data to better understand the mental health needs of cancer patients and survivors and provide effective care.
Links :
Call Launch :
Deadline :
Description :
Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers - Supporting the implementation of the Cancer Mission (HORIZON-MISS-2026-02-CANCER-03).
Expected Outcome:
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:
- Patients with refractory cancers and their caregivers/families will have access to optimised, tailored and affordable immunotherapeutic interventions that increase their quality of life, across European regions, EU Member States and Associated Countries;
- Healthcare professionals and academia will have access to clinical evidence, on effectiveness of immunotherapeutic interventions, to deploy evidence-based treatment interventions with improved patient selection that improve outcomes in real life, i.e. in routine healthcare, for patients with refractory cancers who often present with co-morbidities;
- National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries will have the evidence to implement and reimburse optimised and affordable immunotherapeutic interventions in their healthcare systems, including in everyday medical practice.
Links :
Call Launch :
Deadline :
Description :
Virtual Human Twin (VHT) Models for Cancer Research - Supporting the implementation of the Cancer Mission (HORIZON-MISS-2026-02-CANCER-01).
Expected Outcome:
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:
- Researchers of different disciplines use advanced multiscale Virtual Human Twins (VHTs) to expand the knowledge and understanding of cancer onset and progression
- Healthcare professionals and researchers have access to advanced VHT-based solutions that model cancer onset and progression over time, contributing to improve personalised treatments
- Researchers, healthcare professionals, innovators and citizens have access to cancer VHTs through the UNCAN.eu and the advanced Virtual Human Twin platforms
Links :
Call Launch :
Deadline :
Description :
Supporting the implementation of the Cancer Mission (HORIZON-MISS-2026-02-CANCER-07)
Expected Outcome:
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:
- Improved understanding of care needs of older patients with cancer and approaches to address them.
Older cancer patients gain access to innovative age-specific approaches and tools better tailored to their care needs. - National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated
- Countries have the evidence to implement tailored care for older cancer patients that have the potential to be implemented in routine treatment and follow-up care in their healthcare systems.
Links :
Call Launch :
Deadline :
Description :
Towards a better understanding and anticipation of the impacts of climate change on health - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-ENVHLTH-01).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:
- Citizens, patients, public authorities, social care services, healthcare practitioners and policymakers have a better understanding of the climatic health risks and determinants of disease and are better equipped to address health outcomes through enhanced and inclusive prevention, resilience, adaptation, preparedness and response, including better diagnosis and treatment.
- Governments, public health authorities, researchers and civil society organisations are supported to tackle societal challenges linked to the health impacts of climatic factors.
- Public authorities, organisations and the research community can rely on data collection and sharing according to FAIR[1] principles and leveraging of data availability and quality.
- Policymakers and public authorities develop evidence-based climate change and health policies and interventions that are nature positive, inclusive and responsive to diverse population needs.
Links :
Call Launch :
Deadline :
Description :
Identifying and addressing low-value care in health and care systems - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-CARE-03).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Ensuring equal access to innovative, sustainable, and high-quality healthcare”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Healthcare providers and policymakers make use of evidence-based indicators and methodologies to identify low-value care[1] practices, as well as opportunities for improvement and tools to monitor such improvements.
- Healthcare professionals are equipped with the knowledge and tools to implement guidelines for reducing or discontinuing low-value care activities and maintaining effective and patient-centred practices that ensure quality of care.
- Patients and citizens benefit from more effective healthcare, by understanding and endorsing measures that reduce low-value care, recognising the potential to achieve higher-quality healthcare and better health outcomes overall.
- Health and care systems benefit from a reduction of low-value care practices, which enables enhanced patient safety and quality of care, while contributing to their efficiency as well as fiscal and environmental sustainability.
- Healthcare organisations can, by identifying low-value care practices, reallocate valuable healthcare resources to other areas of need.
Links :
Call Launch :
Deadline :
Description :
Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-TOOL-05).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- The overall competitiveness of the EU biotechnology sector is strengthened through the further development of closer-to-deployment health innovations.
- The EU benefits from greater impact of the EU’s Research and Innovation (R&I) Framework Programmes through successful leveraging of previous EU funding in the field of regenerative medicine.
- EU innovators secure further funding to finalise the last stages of development.
- Patients benefit faster from solutions that improve their health and wellbeing.
Links :
Call Launch :
Deadline :
Description :
Regulatory science to support translational development of patient-centred health technologies - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-IND-03).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to several of the following expected outcomes:
- Policymakers and regulators will get accelerated access to improved evidence driven methodologies to evaluate the impact and efficiency of novel health technologies, facilitating decision-making for their use in humans and uptake in clinical practice.
- Patients and the health systems will benefit from the more targeted and efficient uptake of safe and effective health innovations in clinical practice, supporting more personalised approaches and improved care and public health.
Links :
Call Launch :
Deadline :
Description :
Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-DISEASE-03).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- All players along the healthcare value chain have access to evidence-based treatment and management strategies for post-infection conditions and improve patient recovery and quality of life across diverse populations.
- Public health authorities and healthcare practitioners have access to effective prevention, diagnostic and treatment tools, ensuring better allocation of healthcare resources.
- Healthcare systems improve their efficiency and reduce long-term economic burdens by streamlining post-infectious disease care and addressing disparities in healthcare access.
- Public health authorities have access to evidence-based information to integrate research findings into policy for improved public health preparedness and resilience, including training of healthcare staff and enhanced long-term disease management guidelines.
Links :
Call Launch :
Deadline :
Description :
Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-DISEASE-02).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Researchers and healthcare professionals have an improved understanding of the neuro-biological and cognitive/behavioural evidence base on the correlation and impact of digital technologies on mental health, including brain development.
- Policymakers and digital technology and content developers are provided with a robust evidence base on the impact (positive or negative) of digital technologies on mental health in children and young adults[1].
- Policymakers, digital technology developers, and educational institutions amongst others make use (e.g. developing guidelines) of the evidence base and widely implement the newly developed interventions aimed at promoting children and young adults’ mental health while mitigating any negative impacts of digital technology use.
- Children, young adults, families, guardians, educators, and carers have access to the newly developed interventions designed to prevent harm and promote the positive use of digital technologies.
- Children and young adults are empowered and develop resilience, including digital literacy, enabling them to engage in a healthy and positive way with digital technologies.
Links :
Call Launch :
Deadline :
Description :
Towards climate resilient, prepared and carbon neutral populations and healthcare systems - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-ENVHLTH-04).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:
- The healthcare sector is supported with new technological developments and frameworks for greening, decarbonising and adapting to climate change, thus also contributing to protect biodiversity and ecosystem services.
- Governments, public health authorities, healthcare providers and practitioners, social care services and civil society have access to the best available evidence on the health costs and benefits (including co-benefits) of climate adaptation and mitigation actions and interventions.
- Policymakers and public authorities develop environment, climate change and health policies and interventions based on robust frameworks and incorporating innovative, inclusive and accessible solutions and technologies.
- Governments and public health authorities are supported in their adoption of robust frameworks and interventions to tackle societal challenges linked to the health impacts of climatic and environmental factors.
- Populations are empowered and equipped with knowledge, tools and resources to adopt health-protective behaviours and adapt to health-related climate risks.
Links :
Call Launch :
Deadline :
Description :
Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-TOOL-03).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to several of the following expected outcomes:
- Researchers are in possession of improved human-relevant New Approach Methodologies (NAMs) platforms that capture the genetic, phenotypic, age-related, immune, microbiome, and environmental exposure variability of the human population.
- These innovations support more equitable healthcare solutions and personalised treatment strategies across diverse life stages.
- Industry gets access to platforms that allow a faster pace of innovation for the development of more cost-effective targeted therapeutic interventions and improvement of the safety assessment of chemicals, other medicinal products, and medical devices.
- Patients benefit from innovative platforms and strategies that improve prediction, prevention and treatment of diseases, in particular through enhanced understanding of disease pathways and mechanisms.
- The general population is better protected through a safer environment, as these platforms enhance the detection and mitigation of risks posed by chemicals and other potentially harmful substances.
- Regulatory bodies gain confidence and trust in NAMs, supporting their integration into product development, risk assessment, and approval processes.
- Fewer live animals are used in biomedical research and regulatory testing.
Links :
Call Launch :
Deadline :
Description :
Development of novel vaccines for viral pathogens with epidemic potential - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-DISEASE-04).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- The scientific and clinical communities have a better understanding of and access to experimental vaccines for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation, including better understanding of biological sex and social determinants that influence immune response, vaccine efficacy, safety, and uptake.
- Candidate vaccines are available for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic.
Links :
Call Launch :
Deadline :
Description :
Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-DISEASE-11)
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- Researchers, developers of medical interventions, and healthcare professionals have a better understanding of biological sex and/or gender-specific health determinants, risk factors and pathways for cardiovascular diseases.
- Researchers, developers of medical interventions, and healthcare professionals have access and use sex and/or gender-specific or tailored risk models for better prevention, detection and diagnostic and treatment strategies.
- Healthcare systems benefit from novel sex and/or gender-specific strategies for prevention, detection, diagnosis and treatment options, resulting in reduced burden of cardiovascular diseases.
Links :
Call Launch :
Deadline :
Description :
Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD) - Cluster 1 - Health (Single stage - 2026) HORIZON-HLTH-2026-01-DISEASE-09).
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to some of the following expected outcomes:
- Researchers, policymakers, healthcare- and non-healthcare-related stakeholders and authorities in low- and middle-income countries (LMICs)[1] and/or those in high-income countries (HICs) serving disadvantaged populations have access to improved insights and evidence on how to maximise collaboration and coordination with sectors and in settings beyond the healthcare system in the context of Non-Communicable Diseases (NCDs).
- Researchers, policymakers, healthcare- and non-healthcare-related stakeholders and authorities have an improved understanding how the proposed interventions draw on collaborative multisectoral engagement and utilise the different settings in which people are educated, work and live, to expand efforts to reduce risks, prevent, manage and control NCDs.
- Communities, relevant stakeholders from different sectors and authorities are fully engaged in implementing and taking up interventions that tackle the growing burden of NCDs through actions in sectors and settings outside the traditional health system and its facilities health-related outcomes, improve quality of life across the life course and extend healthy life expectancy.
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Biological, social and environmental factors that impact the trajectory of brain health across the lifespan – in the field of neurological, mental and sensory disorders (EP BrainHealth Call 1).
Maintaining brain health and facing the burden caused by brain disorders, including neurological, neurodegenerative and mental diseases alike, are paramount for all societies in Europe and beyond.
Brain disorders are a leading cause of disability and mortality globally, placing a great burden on people living with brain disorders, their families, social relations, professional and informal carers, as well as healthcare systems and national economies as a whole. In 2021, an estimated 3.4 billion individuals had a condition affecting the nervous system, corresponding to around 43% of the world’s population. This also creates enormous financial pressure on healthcare systems and economies, as the total cost of neurological diseases is estimated at around 1.7 trillion and the economic burden of mental disorders to over 600 billion Euro in Europe per year.
Timeline
- 8th of December 2025 Pre-Announcement
- 8th of January 2026 Launch
- 10th of March 2026 Pre-proposal deadline 14:00 CET
- End of May 2026 Formal invitation to submit a full proposal
- 30th of June, 2026 Submission deadline of full proposals 14:00 CEST
- September, 2026 Peer Review Panel meeting to assess the full proposals
- November 2026 Final funding decision by the CSC and start of national administrative procedures
- Early – Mid 2027 Start of funding
Call Launch :
Deadline :
Description :
IHI call 12 is a single-stage, applicant-driven call with topics aligned with the specific objectives of the IHI Strategic Research and Innovation Agenda.
Topics
The call contains five topics, each focusing on one of the five IHI Specific Objectives (SOs) as set out in the Strategic Research and Innovation Agenda (SRIA):
- Topic 1 (SO1): Boosting innovation for a better understanding of the determinants of health
- Topic 2 (SO2): Boosting innovation through better integration of fragmented health R&I effort
- Topic 3 (SO3): Boosting innovation for people-centred integrated healthcare solutions
- Topic 4 (SO4): Boosting innovation through exploitation of digitalisation and data exchange in healthcare
- Topic 5 (SO5): Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions
For full details of the topics, including the budget breakdown, read the call text. All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page. We advise you to read these documents, in particular the guide for applicants, carefully.
Important information on eligibility for funding
Applicants should note that legal entities based in the following countries are not eligible to receive funding for some of the topics in this call.
Key dates and deadlines
- Call outline announced: 23 September 2025. Draft topic texts published: 14 October 2025, updated 18 November 2025. Approved topics published: 11 December 2025.
- Call launch: 15 January 2026
- Full proposal submission deadline: 21 April 2026 at 17:00 Brussels time
Other useful information
Call ID: HORIZON-JU-IHI-2026-12-SINGLE-STAGE | Action type: RIA - Research and Innovation Actions | Call type: Single-stage
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Pre-announcement of the Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases (Trials4Health) call
The Partnership “Fostering a European Research Area for Health” (ERA4Health) brings the opportunity to increase European transnational collaborative research funding by creating a funding body for joint programming in priority areas addressing European Public Health Needs.
Under this umbrella, ERA4Health is glad to pre-announce the launch of its seventh Joint Transnational Call (JTC), that will fund: “Multi-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases” (Trials4Health).
The aims of the call are:
- To support randomised interventional multi-country Investigator-Initiated Clinical Studies that are designed as pragmatic comparative-effectiveness studies and/or drug repurposing studies.
- To encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct multi-country IICS, either comparative-effectiveness or drug repurposing studies.
Call Launch :
Deadline :
Deadline 2 :
Description :
IHI call 11 is a two-stage call with topics on brain dysfunction, the link between infections and non-communicable diseases, pharmacovigilance, type 1 diabetes, and ambulatory surgical centres.
Key dates and deadlines
- Draft topic texts published: 10 April, updated 23 May
- Call launch: 17 June 2025
- Short proposal submission deadline: 9 October 2025 at 17:00 Brussels time
- Full proposal submission deadline: 29 April 2026 at 17:00 Brussels time
Other useful information
Call ID: HORIZON-JU-IHI-2025-11-two-stage | Action type: RIA - Research and Innovation Actions | Call type: Two-stage
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
EP PerMed Research Innovation and Technology Call (RITC) 2026
The European Partnership for Personalised Medicine, EP PerMed supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.
The call will be implemented in two stages: a pre and a full proposal phase.
Expected timeline of the call
- 1 October 2025: Publication of the call
- 28 October 2025: RITC2026 Information Day – online webinar
- 18 November 2025: RITC2026 Matchmaking Event – online event
- 12 January 2026 (14:00, CET): Deadline for pre-proposal submission
- Expected around 19 March 2026: Communication of the results of the pre-proposal assessment and invitation to the full proposal stage
- 27 April 2026 (14:00, CEST): Deadline for full-proposal submission
- End of June 2026: Rebuttal stage
- Expected for beginning of September 2026: Communication of the funding decisions to the applicants
- End of 2026, beginning of 2027: 6-months starting phase (development of Consortium Agreement, Data Management Plan and Ethics Approvals).
Expected scientific project start. Establishment of funding contracts with funding organisations (according to regional/national funding regulations).
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Advancing knowledge on the impacts of micro- and nanoplastics on human health
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed, tailored and contributing to most of the following expected outcomes:
- Environmental and health policies reducing exposure to micro- and nanoplastics and preventing their potential health impacts are supported with up-to-date scientific evidence, standards, tools and methodologies;
Public authorities and the scientific community have access to FAIR[1] data on realistic human exposures to micro- and nanoplastics and their potential impacts on human health based on real-world scenarios across living and working environments; - Citizens are informed about the impacts of exposure to micro- and nanoplastics on health and adopt behaviours protecting health and reducing human impacts on the environment;
Industry is supported in the assessment of products’ safety and sustainability; - Existing major knowledge gaps in the understanding of the health impacts of exposure to micro- and nanoplastics are filled and mitigation measures based on robust evidence are promoted;
- Public authorities and regulators are supported with evidence-based guidance to design health policies.
Please note that the first deadline has now passed and the second closed 16 April 2026 17:00:00 Brussels time.
Links :
Call Launch :
Deadline :
Deadline 2 :
Description :
Improving the quality of life of persons with intellectual disabilities and their families
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed, tailored and contributing to most of the following expected outcomes:
- Global and EU policies preventing and reducing the health impacts of pollution are supported with up-to-date scientific evidence, tools and methodologies;
- Citizens are more protected by having a better insight into exposure to pollution and its impacts on brain health and adopting health enhancing behaviours;
- Public authorities, health stakeholders, the scientific community and the society at large have access to FAIR[1] data on the link between pollution and brain health, particular windows of susceptibility to exposure and the impacts of pollution on the general population and vulnerable groups;
- Public authorities develop adequate evidence-based measures and guidelines to prevent and reduce the negative impacts of pollution in the development of brain disease.
Please note that the first deadline has now passed and the second closed 16 April 2026 17:00:00 Brussels time.
Links :